Tony Johnson

Tony Johnson has a diverse work experience in the pharmaceutical industry, spanning over several years. Tony is currently employed at Mallinckrodt Pharmaceuticals as the Senior Director of Global Clinical Quality Assurance, where they are responsible for developing and maintaining a program to ensure compliance with regulatory standards. Prior to this, they held positions at Regeneron Pharmaceuticals, Inc. as Director, Clinical Compliance and Associate Director, Clinical Compliance. Tony has also worked at Mitsubishi Pharma America, Inc. and Mitsubishi Pharma America as a Senior Manager of Quality Management and Manager of Quality Management respectively. Additionally, they have served as a GMP Auditor at Forest Laboratories and a Compliance Auditor and Project Specialist at Berlex Laboratories. Tony began their career as a Chemist at Schein Pharmaceuticals.

Tony Johnson earned a Master of Science degree in Pharmaceutical Drug and Medical Device Law from Seton Hall University (2021-2023). Prior to that, they obtained a Master of Science degree in QA/RA from Temple University (2007-2010). Their undergraduate education includes a Bachelor of Science degree in Chemistry from SUNY New Paltz (1986-1990). No information is provided about their high school education. In addition, Tony has obtained certifications in A2E Business Fundamentals and Management Accelerator Program from McKinsey & Company in 2022.